Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

919
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
919
Humoral Immune Responses01:36

Humoral Immune Responses

72.2K
Overview
72.2K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

67.8K
Overview
67.8K
What is the Immune System?01:38

What is the Immune System?

110.9K
Overview
110.9K
T Cell Types and Functions01:24

T Cell Types and Functions

960
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
960
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

764
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
764

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delayed identification and treatment of a cervicomedullary spinal vascular lesion following angiogram-negative, high-grade subarachnoid hemorrhage: illustrative case.

Journal of neurosurgery. Case lessons·2026
Same author

Evaluating the Risk of <i>Clostridioides difficile</i> Infection After Rifaximin Treatment for Small Intestinal Bacterial Overgrowth.

Journal of clinical medicine·2026
Same author

Safety of Live Attenuated MMR, Varicella, and Yellow Fever Vaccination in Patients with Inflammatory Bowel Disease Receiving Biologic and Targeted Synthetic Therapy: A Propensity-Score-Matched Analysis.

Vaccines·2026
Same author

Global fits and the search for new physics: past, present and future.

Science bulletin·2026
Same author

Impact of cirrhosis on patients admitted with an exacerbation of acute chronic obstructive pulmonary disease: a nationwide analysis.

Proceedings (Baylor University. Medical Center)·2026
Same author

Predictors of a Nonroutine Discharge After Surgical Treatment of an Unruptured Intracranial Aneurysm: An American College of Surgeons National Surgical Quality Improvement Program Study.

World neurosurgery·2026
Same journal

Key factors in the diagnosis of sesame allergy in children.

Allergy and asthma proceedings·2026
Same journal

Immunoglobulin E-mediated pumpkin seed allergy in children: Case series and narrative review with a structured literature search.

Allergy and asthma proceedings·2026
Same journal

Predictors of delayed treatment-free remission with omalizumab in chronic spontaneous urticaria.

Allergy and asthma proceedings·2026
Same journal

The digital front door: A national analysis of U.S. allergy and immunology fellowship program web sites.

Allergy and asthma proceedings·2026
Same journal

The impact of dietary patterns on the risk of asthma in children.

Allergy and asthma proceedings·2026
Same journal

The alpha-gal syndrome: Understanding the role of tick bites, and the delays in severe anaphylaxis.

Allergy and asthma proceedings·2026
See all related articles

Related Experiment Video

Updated: Jun 12, 2025

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

8.9K

Immunodysregulation in immunodeficiency.

Christopher Chang

    Allergy and Asthma Proceedings
    |September 19, 2024
    PubMed
    Summary
    This summary is machine-generated.

    Primary immunodeficiencies often involve immune dysfunction, leading to autoimmunity and lymphoproliferation. Understanding genetic causes helps tailor treatments for inborn errors of immunity (IEI) and mitigate infection risks.

    More Related Videos

    Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
    14:01

    Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

    Published on: July 22, 2011

    14.5K
    In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
    09:26

    In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

    Published on: October 15, 2013

    14.1K

    Related Experiment Videos

    Last Updated: Jun 12, 2025

    Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
    10:13

    Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

    Published on: May 6, 2019

    8.9K
    Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
    14:01

    Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

    Published on: July 22, 2011

    14.5K
    In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
    09:26

    In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

    Published on: October 15, 2013

    14.1K

    Area of Science:

    • Immunology
    • Genetics
    • Medicine

    Background:

    • Primary immunodeficiency diseases (PIDs) frequently present with autoimmunity, autoinflammation, or lymphoproliferation.
    • The complex interactions within immune networks explain the paradoxical association between immunodeficiency and immune dysregulation.
    • A growing number of PIDs are identified with genetic etiologies, highlighting the concept of inborn errors of immunity (IEI).

    Purpose of the Study:

    • To elucidate the intricate relationship between primary immunodeficiencies and associated autoimmune/autoinflammatory conditions.
    • To emphasize the importance of recognizing these comorbidities in clinical practice.
    • To advocate for mechanism-based and targeted therapeutic strategies for IEIs.

    Main Methods:

    • Review of the literature on primary immunodeficiencies and associated conditions.
    • Analysis of the immunological and genetic underpinnings of immune dysregulation in IEIs.
    • Discussion of current and emerging treatment paradigms.

    Main Results:

    • PIDs are commonly associated with autoimmune cytopenias, inflammatory bowel disease, autoimmune thyroiditis, autoimmune liver diseases, lymphomas, and cancers.
    • Treatment with immunosuppression for immune dysregulation increases infection risk in PID patients.
    • Mechanism-based approaches targeting specific cells or molecules, such as cytokines, are crucial for effective therapy.

    Conclusions:

    • Inborn errors of immunity (IEI) represent a spectrum of immune dysfunctions, often accompanied by autoimmunity and lymphoproliferation.
    • Awareness of these frequent comorbidities is essential for clinicians managing patients with PIDs.
    • Personalized, mechanism-based therapies targeting specific molecular or cellular pathways offer a promising future for IEI treatment.